This study aimed to evaluate the IHC expression of CDX2 protein in HGC patients and control groups and also to study the correlation between IHC expression of the CDX2 and different clinicopathological variables such as: age, gender, histopathological subtype, grade, and stage of the tumor in HGC cases. the retrospectively sectional study for the period from 2014 to 2018 included a total of 60 formalin fixed paraffin embedded blocks of the HGC tissue (partial or total gastrectomy specimens) that collected from the archived materials of the Department of Pathology of Baghdad Teaching Hospital and the Center of Gastrointestinal and Hepatic Diseases, and also some samples were collected from other private laboratories. The IHC expression of the CDX2 was significantly increased in HGC group compared with control groups (p< 0.0001). A clinic-pathological assessment revealed that patient’s samples involved 20 males and 10 females; Male to female ratio was 2: 1. The age of patients was ranged between 18-76 years with a mean±standard error of (48.39±12.39) year. The majority of the HGC cases, in this study (53.3%) were above 48 years of age. the commonest histopathological subtype was the diffuse subtype (46.6%).
